Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease

Apr 2, 2025Scientific reports

Microglial TLR4-Lyn kinase controls brain inflammation, amyloid removal, nerve cell damage, and survival in Alzheimer's disease

AI simplified

Abstract

An increased direct protein-protein interaction between and was observed in the brains of 5XFAD mice compared to wild-type mice.

  • The interaction between TLR4 and Lyn kinase may influence inflammatory and phagocytosis signaling pathways in Alzheimer's disease.
  • In the absence of Lyn, 5XFAD x Lyn mice showed increased expression of protective Syk kinase and enhanced Aβ phagocytosis.
  • Increased astrocyte activity and decreased neuronal dystrophy were noted in 5XFAD x Lyn mice.
  • in 5XFAD mice exhibited higher levels of TLR4 and Lyn, along with greater inflammatory cytokine production.
  • In vitro treatment with TLR4-Lyn Interaction Modulators (TLIMs) resulted in increased Aβ phagocytosis and decreased neuronal dystrophy.

AI simplified

Key numbers

1.5×
Increase in Population
Comparing populations in Lyn-deficient vs. control 5XFAD mice.
17.9 nM
TLIM IC50 Concentration
Determined through dose-response curve for TLIM treatment.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free